INVASIVENESS INVITRO VERSUS CLINICAL EVOLUTION OF PRIMARY AND SECONDARY BRAIN-TUMORS

被引：0

作者：

DERIDDER, L ^{[1
]}

CALLIAUW, L ^{[1
]}

机构：

[1] STATE UNIV GHENT HOSP,DEPT NEUROSURG,B-9000 GENT,BELGIUM

来源：

INTERNATIONAL JOURNAL OF ONCOLOGY | 1993年 / 2卷 / 01期

关键词：

BRAIN TUMORS; CELL CULTURE; INVASIVENESS; GLIOMA;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Cells of 56 primary cell cultures derived from primary and secondary brain tumours were confronted in vitro with host tissue, embryonic chick heart fragments (PHF). The evolution of the confrontation was followed for one week. Histological analysis of the confrontations demonstrated two different patterns. (i) Survival of host tissue and tumour derived cells without invasion of the last ones into the host. (ii) Invasion of tumour derived cells into the host tissue followed by replacement of the chick heart tissue. Invasion into the host tissue was observed only in the confrontations with primary cell cultures originating from malignant and metastatic tumours. The invasive characters in vitro of primary cell cultures correlated with the malignancy of the tumour in vivo.

引用

页码：85 / 88

页数：4

共 39 条

[31] The History, Evolution, and Clinical use of Dendritic Cell-Based Immunization Strategies in the Therapy of Brain Tumors [J].

Peter E. Fecci ;

Duane A. Mitchell ;

Gary E. Archer ;

Michael A. Morse ;

H. Kim Lyerly ;

Darell D. Bigner ;

John H. Sampson .

Journal of Neuro-Oncology, 2003, 64 :161-176

[32] The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumors [J].

Peter E. Fecci ;

Duane A. Mitchell ;

Gary E. Archer ;

Michael A. Morse ;

H. Kim Lyerly ;

Darell D. Bigner ;

John H. Sampson .

Journal of Neuro-Oncology, 2003, 64 (1-2) :161-176

[33] The clinical impact of amino acid positron emission tomography measurements in the treatment of primary malignant brain tumors [J].

Katalin, Borbely ;

Istvan, Kenessey ;

Imre, Fedorcsak ;

Gergo, Nagy David .

ORVOSI HETILAP, 2023, 164 (32) :1247-1255

[34] Clinical Predictors of Depression in Patients with Low-Grade Brain Tumors: Consideration of a Neurologic Versus a Psychogenic Model [J].

Carol L. Armstrong ;

Bram Goldstein ;

Brian Cohen ;

Mi-Yeoung Jo ;

Emily M. Tallent .

Journal of Clinical Psychology in Medical Settings, 2002, 9 :97-107

[35] Clinical predictors of depression in patients with low-grade brain tumors: Consideration of a neurologic versus a psychogenic model [J].

Armstrong, CL ;

Goldstein, B ;

Cohen, B ;

Jo, MY ;

Tallent, EM .

JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS, 2002, 9 (02) :97-107

[36] PRIMARY BRAIN-TUMORS DIFFER IN THEIR EXPRESSION OF OCTAMER DEOXYRIBONUCLEIC-ACID BINDING TRANSCRIPTION FACTORS FROM LONG-TERM CULTURED GLIOMA CELL-LINES [J].

SCHREIBER, E ;

MERCHANT, RE ;

WIESTLER, OD ;

FONTANA, A ;

KORNBLITH, PL ;

REMPEL, SA ;

ROSENBLUM, ML .

NEUROSURGERY, 1994, 34 (01) :129-135

[37] Clinical outcomes from maximum-safe resection of primary and metastatic brain tumors using awake craniotomy [J].

Groshev, Anastasia ;

Padalia, Devang ;

Patel, Sephalie ;

Garcia-Getting, Rosemarie ;

Sahebjam, Solmaz ;

Forsyth, Peter A. ;

Vrionis, Frank D. ;

Etame, Arnold B. .

CLINICAL NEUROLOGY AND NEUROSURGERY, 2017, 157 :25-30

[38] FEASIBILITY STUDY OF INTRAARTERIAL VS INTRAVENOUS CISPLATIN, BCNU, AND TENIPOSIDE COMBINED WITH SYSTEMIC CISPLATIN, TENIPOSIDE, CYTOSINE-ARABINOSIDE, GLYCEROL AND MANNITOL IN THE TREATMENT OF PRIMARY AND METASTATIC BRAIN-TUMORS [J].

STEWART, DJ ;

GRAHOVAC, Z ;

HUGENHOLTZ, H ;

DASILVA, V ;

RICHARD, MT ;

BENOIT, B ;

BELANGER, G ;

RUSSELL, N .

JOURNAL OF NEURO-ONCOLOGY, 1993, 17 (01) :71-79

[39] Determination of HER-2/neu overexpression and clinical predictors of survival in a cohort of 347 patients with primary malignant brain tumors [J].

Potti, A ;

Forseen, SE ;

Koka, VK ;

Pervez, H ;

Koch, M ;

Fraiman, G ;

Mehdi, SA ;

Levitt, R .

CANCER INVESTIGATION, 2004, 22 (04) :537-544

← 1 2 3 4 →